acetylcysteine has been researched along with tetracycline in 20 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (20.00) | 18.7374 |
| 1990's | 1 (5.00) | 18.2507 |
| 2000's | 8 (40.00) | 29.6817 |
| 2010's | 7 (35.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Abouelhassan, Y; Bai, F; Burch, GM; Garrison, AT; Huigens, RW; Jin, S; Kallifidas, D; Luesch, H; Nguyen, MT; Norwood, VM; Rolfe, M | 1 |
| Carnimeo, N; Iaia, E | 1 |
| Allegra, L; Gioia, V; Monastero, A | 1 |
| Chirila, TV; Clayton, AB; Constable, IJ; Crawford, GJ; Fitton, JH; Hicks, CR; Ziegelaar, BW | 1 |
| Camps, M; Kloetzel, PM; Melief, C; Offringa, R; Ossendorp, F; Sijts, A | 1 |
| Dawson, TM; Engelender, S; Igarashi, S; L Dawson, V; Rao, RK; Ross, CA; Sawa, A; Tanaka, Y; Tanzi, RE; Wanner, T | 1 |
| Avila, J; Hen, R; Hernández, F; Lucas, JJ; Martín-Aparicio, E; Yamamoto, A | 1 |
| GAFFURI, E; GALZIGNA, L; REGGIANI, A | 1 |
| LAWSON, D; SAGGERS, BA | 1 |
| Bitter-Suermann, S; Kanniess, F; Magnussen, H; Watz, H | 1 |
| Ekor, M; Ezenwadu, TT; Farombi, EO; Oyeyemi, MO; Ugwuezunmba, MC | 1 |
| Jang, EY; Lee, JY; Moon, JH; Shim, KS | 1 |
| Kimmitt, BA; Moore, GE; Stiles, J | 1 |
2 review(s) available for acetylcysteine and tetracycline
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
[Pharmacological treatment of COPD and future of anti-inflammatory therapy].
Topics: Acetylcysteine; Administration, Inhalation; Adrenal Cortex Hormones; Adrenergic beta-Agonists; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Bronchodilator Agents; Carboxylic Acids; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Dyspnea; Expectorants; Forced Expiratory Volume; Forecasting; Humans; Inflammation; Infliximab; Lung; Macrolides; Nitriles; Phosphodiesterase Inhibitors; Pilot Projects; Pulmonary Disease, Chronic Obstructive; Randomized Controlled Trials as Topic; Research; Respiratory Function Tests; Simvastatin; Smoking Cessation; Tetracycline; Theophylline; Tumor Necrosis Factor-alpha | 2006 |
18 other study(ies) available for acetylcysteine and tetracycline
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Structure-Activity Relationships of a Diverse Class of Halogenated Phenazines That Targets Persistent, Antibiotic-Tolerant Bacterial Biofilms and Mycobacterium tuberculosis.
Topics: Biofilms; Carbon-13 Magnetic Resonance Spectroscopy; Drug Resistance, Bacterial; Drug Screening Assays, Antitumor; Halogens; HeLa Cells; Humans; Microbial Sensitivity Tests; Mycobacterium tuberculosis; Phenazines; Proton Magnetic Resonance Spectroscopy; Structure-Activity Relationship | 2016 |
[Experiences on aerosol treatment of bronchopulmonary diseases with tetracycline-1-methylene-lysine combined with acetylcysteine].
Topics: Acetylcysteine; Adolescent; Adult; Aged; Bronchial Diseases; Female; Heart Diseases; Humans; Lung Diseases; Lymecycline; Male; Middle Aged; Tetracycline | 1965 |
[Prospects of research on the behavior of endoalvlar surface tension ar aerosol administration of pharmacological substances].
Topics: Acetylcysteine; Aerosols; Animals; Lung; Pulmonary Alveoli; Rats; Surface Tension; Tetracycline | 1967 |
Assessment of anticollagenase treatments after insertion of a keratoprosthetic material in the rabbit cornea.
Topics: Acetylcysteine; Administration, Topical; Animals; Blotting, Western; Citrates; Collagenases; Cornea; Disease Models, Animal; Electrophoresis, Polyacrylamide Gel; Gelatinases; Graft Survival; Implants, Experimental; Matrix Metalloproteinase Inhibitors; Medroxyprogesterone; Methacrylates; Ophthalmic Solutions; Prednisolone; Rabbits; Sodium Citrate; Tetracycline; Treatment Outcome | 1998 |
Differential influence on cytotoxic T lymphocyte epitope presentation by controlled expression of either proteasome immunosubunits or PA28.
Topics: Acetylcysteine; Animals; Antigen Presentation; ATP Binding Cassette Transporter, Subfamily B, Member 2; ATP-Binding Cassette Transporters; Autoantigens; Blotting, Western; Cell Cycle Proteins; Cell Line; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Enzyme-Linked Immunosorbent Assay; Epitopes, T-Lymphocyte; Histocompatibility Antigens Class I; Interferon-gamma; Leukemia Virus, Murine; Mice; Mice, Inbred C57BL; Multienzyme Complexes; Precipitin Tests; Proteasome Endopeptidase Complex; Proteins; Rats; Sulfones; T-Lymphocytes, Cytotoxic; Tetracycline | 2000 |
Inducible expression of mutant alpha-synuclein decreases proteasome activity and increases sensitivity to mitochondria-dependent apoptosis.
Topics: Acetylcysteine; alpha-Synuclein; Animals; Apoptosis; Blotting, Western; Caspase 3; Caspase 9; Caspases; Cyclosporine; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Gene Expression Regulation; Immunoenzyme Techniques; Membrane Potentials; Mitochondria; Multienzyme Complexes; Mutation; Nerve Tissue Proteins; Parkinson Disease; PC12 Cells; Proteasome Endopeptidase Complex; Rats; Synucleins; Tetracycline; Transfection | 2001 |
Proteasomal-dependent aggregate reversal and absence of cell death in a conditional mouse model of Huntington's disease.
Topics: Acetylcysteine; Animals; Behavior, Animal; Cell Death; Cell Survival; Cells, Cultured; Corpus Striatum; Cysteine Endopeptidases; Disease Models, Animal; Gene Silencing; Genes, Dominant; Huntingtin Protein; Huntington Disease; Locomotion; Macromolecular Substances; Mice; Mice, Neurologic Mutants; Multienzyme Complexes; Nerve Tissue Proteins; Neurons; Nuclear Proteins; Phenotype; Proteasome Endopeptidase Complex; Remission Induction; Tetracycline; Transgenes; Ubiquitin | 2001 |
[EFFECTS OF THE AEROSOL ADMINISTRATION OF N-ACETYL-L-CYSTEINE COMBINED WITH A TETRACYCLINE ON THE PHYSICAL CHARACTERISTICS OF BRONCHIAL SECRETIONS AND SUBJECTIVE SYMPTOMS IN CHRONIC BRONCHITIS].
Topics: Acetylcysteine; Aerosols; Anti-Bacterial Agents; Bronchi; Bronchitis; Bronchitis, Chronic; Cysteine; Humans; Pharmacology; Tetracycline | 1963 |
N.A.C. AND ANTIBIOTICS IN CYSTIC FIBROSIS.
Topics: Acetylcysteine; Ampicillin; Anti-Bacterial Agents; Antibiotics, Antitubercular; Cysteine; Cystic Fibrosis; Erythromycin; Fusidic Acid; Humans; Penicillins; Pharmacology; Protein Synthesis Inhibitors; Tetracycline | 1965 |
Tetracycline-induced reproductive toxicity in male rats: effects of vitamin C and N-acetylcysteine.
Topics: Acetylcysteine; Administration, Oral; Animals; Anti-Bacterial Agents; Ascorbic Acid; Catalase; Drug Therapy, Combination; Free Radical Scavengers; Glucosephosphate Dehydrogenase; Glutathione; Glutathione Transferase; Male; Organ Size; Oxidative Stress; Rats; Sperm Count; Sperm Motility; Spermatozoa; Superoxide Dismutase; Testicular Diseases; Testis; Testosterone; Tetracycline | 2008 |
In vitro effects of N-acetyl cysteine alone and in combination with antibiotics on Prevotella intermedia.
Topics: Acetylcysteine; Ampicillin; Anti-Bacterial Agents; Biofilms; Ciprofloxacin; Metronidazole; Microbial Sensitivity Tests; Prevotella intermedia; Tetracycline | 2015 |
Comparison of the efficacy of various concentrations and combinations of serum, ethylenediaminetetraacetic acid, tetracycline, doxycycline, minocycline, and N-acetylcysteine for inhibition of collagenase activity in an in vitro corneal degradation model.
Topics: Acetylcysteine; Animals; Anti-Bacterial Agents; Collagenases; Cornea; Corneal Diseases; Disease Models, Animal; Dogs; Doxycycline; Edetic Acid; Horses; Matrix Metalloproteinase Inhibitors; Minocycline; Serum; Tetracycline | 2018 |